Study record

Serum Mitochondrial Open Reading Frame of the 12S rRNA-c (MOTS-c) Dynamics as a Complementary Marker of Treatment Response in Newly Diagnosed Multiple Myeloma: A Prospective Analysis

Erol V, Avci E, Kabukcu Hacioglu S et al. · Cureus · 2025

Human obs.Endogenous MOTS-c measuredEvidence tier B

What this study reported

Measured serum MOTS-c before and after frontline treatment in adults with newly diagnosed multiple myeloma and reported a substantial post-treatment increase in responders, with little or no change in refractory cases. Found that post-treatment MOTS-c values correlated inversely with changes in calcium and neutrophil count. Reported limited standalone predictive capacity for MOTS-c in this cohort.

Limitations

Small single-cohort sample of 29 patients with no untreated comparison group, heterogeneous frontline regimens, and exploratory correlational analyses without adjustment or external validation.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedEndogenous MOTS-c measuredNaturally occurring MOTS-c was measured; nothing was given.
Specieshuman
System studiedPatients newly diagnosed with multiple myeloma sampled before and after frontline treatment
Populationadults newly diagnosed with multiple myeloma
DesignProspective single-arm cohort with paired pre- and post-treatment sampling
Sample size as reported29 patients with multiple myeloma
Control groupNot reported
Route (data field only)Not reported
Endpoints measuredserum MOTS-c concentration; treatment response status; serum calcium; neutrophil count
Pathways measuredNot reported
Research areasCancer · Mitochondrial biology
Evidence tierB — Other human study
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Small
Controls
None
Outcome validity
Exploratory
Support for its own conclusion
Weak

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.